Advertisement

Topics

Pharmaceutiques Company Profile

05:59 EDT 22nd September 2017 | BioPortfolio

Nil

Location

22 avenue d'Eylau
Paris
75116
France

Contact

Phone: 33 (0) 1.44.05.83.00
Fax: 33 (0) 1.44.05.83.18


News Articles [2 Associated News Articles listed on BioPortfolio]

Societe des Industries Pharmaceutiques de Tunisie SA SIPHA Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummarySociete des Industries Pharmaceutiques de Tunisie SA SIPHAT manufactures and markets generic drugs. The company offers generic drugs in therapeutic areas such as allergology, analgesicantipyret...

Societe des Industries Pharmaceutiques de Tunisie SA SIPHA Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummarySociete des Industries Pharmaceutiques de Tunisie SA SIPHAT manufactures and markets generic drugs. The company offers generic drugs in therapeutic areas such as allergology, analgesicantipyret...

Drugs and Medications [0 Results]

None

PubMed Articles [18 Associated PubMed Articles listed on BioPortfolio]

A survey of pharmacists' knowledge and views of biosimilars in Quebec and France.

The objective of this study was to survey pharmacists' knowledge and views of biosimilars in Quebec and France.

The topological phase diagram of cimetidine: A case of overall monotropy.

Cimetidine is a histamine H2-receptor antagonist used against peptic ulcers. It is known to exhibit crystalline polymorphism. Forms A and D melt within 0.35 degrees from each other and the enthalpies ...

Investigation of a Potential Pharmacokinetic Interaction Between Nebivolol and Fluvoxamine in Healthy Volunteers.

To investigate whether fluvoxamine coadministration can influence the pharmacokinetic properties of nebivolol and its active hydroxylated metabolite (4-OH-nebivolol) and to assess the consequences of ...

Effectiveness of Valganciclovir 900mg Versus 450mg for Cytomegalovirus Prophylaxis in Renal Transplantation: A Systematic Review and Meta-Analysis.

Valganciclovir 900 mg/day is approved for cytomegalovirus (CMV) prophylaxis, but 450 mg/day is seems also effective. We systematically reviewed the efficacy and safety of low-dose versus high-dose val...

Levodopa in Parkinson's Disease: A Review of Population Pharmacokinetics/Pharmacodynamics Analysis.

Parkinson's disease is the second most common neurodegenerative disorder after Alzheimer's disease. Although levodopa remains the single effective agent in the management of Parkinson's disease, the a...

Clinical Trials [0 Results]

None

More Information about "Pharmaceutiques" on BioPortfolio

We have published hundreds of Pharmaceutiques news stories on BioPortfolio along with dozens of Pharmaceutiques Clinical Trials and PubMed Articles about Pharmaceutiques for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmaceutiques Companies in our database. You can also find out about relevant Pharmaceutiques Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record